Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Afq056
1. 543906-09-8
2. Afq056
3. Afq-056
4. (3ar,4s,7ar)-octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1h-indole-1-carboxylic Acid Methyl Ester
5. Gt0i9sv4f6
6. Methyl (3ar,4s,7ar)-4-hydroxy-4-(m-tolylethynyl)octahydro-1h-indole-1-carboxylate
7. 1h-indole-1-carboxylic Acid, Octahydro-4-hydroxy-4-(2-(3-methylphenyl)ethynyl)-, Methyl Ester, (3ar,4s,7ar)-
8. Methyl (3ar,4s,7ar)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-3,3a,5,6,7,7a-hexahydro-2h-indole-1-carboxylate
9. (-)-(3ar,4s,7ar)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic Acid Methyl Ester
10. Mavoglurant [inn]
11. Mavoglurant [usan:inn]
12. Unii-gt0i9sv4f6
13. Afq 056
14. 4oo9
15. Mavoglurant, Afq056
16. Mavoglurant [usan]
17. Mavoglurant [who-dd]
18. Schembl989279
19. Gtpl7586
20. Chembl3087515
21. Dtxsid30202777
22. Bcp20624
23. Ex-a1564
24. Zinc3817189
25. Bdbm50443085
26. Cs-5245
27. Db13004
28. As-79009
29. Hy-15257
30. Db-102250
31. Q6589598
32. (3ar,4s,7ar)-methyl 4-hydroxy-4-(m-tolylethynyl)octahydro-1h-indole-1-carboxylate
33. Methyl (3ar,4s,7ar)-4-hydroxy-4-[(3-methylphenyl)ethynyl]octahydro-1h-indole-1-carboxylate
34. 1h-indole-1-carboxylic Acid, Octahydro-4-hydroxy-4-((3-methylphenyl)ethynyl)-, Methyl Ester, (3ar,4s,7ar)-
35. 2u8
36. Methyl (3ar,4s,7ar)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]octahydro-1h-indole-1-carboxylate
| Molecular Weight | 313.4 g/mol |
|---|---|
| Molecular Formula | C19H23NO3 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 49.8 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 519 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Mavoglurant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mavoglurant, including repackagers and relabelers. The FDA regulates Mavoglurant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mavoglurant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mavoglurant supplier is an individual or a company that provides Mavoglurant active pharmaceutical ingredient (API) or Mavoglurant finished formulations upon request. The Mavoglurant suppliers may include Mavoglurant API manufacturers, exporters, distributors and traders.
Mavoglurant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mavoglurant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mavoglurant GMP manufacturer or Mavoglurant GMP API supplier for your needs.
A Mavoglurant CoA (Certificate of Analysis) is a formal document that attests to Mavoglurant's compliance with Mavoglurant specifications and serves as a tool for batch-level quality control.
Mavoglurant CoA mostly includes findings from lab analyses of a specific batch. For each Mavoglurant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mavoglurant may be tested according to a variety of international standards, such as European Pharmacopoeia (Mavoglurant EP), Mavoglurant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mavoglurant USP).
LOOKING FOR A SUPPLIER?
